Penumbra Study Supports Mechanical Thrombectomy for Pulmonary Embolism Treatment
Penumbra announced positive results from the STORM-PE trial, showing its computer-assisted vacuum thrombectomy system reduced right heart strain in patients with acute intermediate high-risk pulmonary embolism.
- The study compared the use of Penumbra's system with anticoagulation to anticoagulation alone.
- The company's Lightning Flash system features Lightning Intelligent Aspiration technology and dual clot detection algorithms.
The findings were presented at the 2025 Transcatheter Cardiovascular Therapeutics conference in San Francisco.
No direct quote available in the text.
Author's summary: Penumbra's study backs mechanical thrombectomy for pulmonary embolism treatment.
More News
- Government Shutdown Deepens: Senate Vote Fails For 13th Time As Food, Pay Crisis Loom
- Sugar Hill man arrested for banging on door of a Hall Co. home with rifle
- Trump administration to shake up ICE leadership to boost deportation levels
- We need more faith spaces that affirm the LGBTQ communities – Baptist News Global
- Saints hand keys to rookie Tyler Shough after brutal 1-7 start
- Arsenal to hand leading star HUGE pay rise as negotiations 'progress' over crucial agreement - journalist
- Kieran McKenna Linked with Celtic Job
- Nokia commits to full AI-RAN GPU play on new Nvidia RAN compute platform - The Mobile Network
- OpenAI completes for-profit shift, gives Microsoft 27% stake
- The museum and the mass grave: How colonial powers curate our pain